EDDIE THARA D.O.
Prescription History 1932436821
Internal Medicine - Hematology & Oncology in Downey, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for EDDIE THARA D.O., an active Hematology & Oncology specialist practicing in Downey, CA. Our medical registry currently tracks 36 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,330 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 141 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Anastrozole | 141 | $39.03 | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2023, this provider wrote 141 Medicare prescriptions for Anastrozole, about 2.1 times the volume of the typical California prescriber of this medication (68). Medicare paid an average of $39.03 per fill, versus $27.13 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 349 30-Day Fills standardized to 30-day supplies 10,470 Days of Medication total across all patients in 2023 | |||
| Prednisone | 116 | $8.63 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 116 Medicare prescriptions for Prednisone, about 2.9 times the volume of the typical California prescriber of this medication (40). Medicare paid an average of $8.63 per fill, versus $8.18 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 132.1 30-Day Fills standardized to 30-day supplies 3,491 Days of Medication total across all patients in 2023 | |||
| Dexamethasone Sodium Phosphate | 96 | $2.94▼ below CA avg | ▲ More than typical |
About Dexamethasone Sodium Phosphate: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. This injectable form of dexamethasone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of dexamethasone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. In 2023, this provider wrote 96 Medicare prescriptions for Dexamethasone Sodium Phosphate, about 2 times the volume of the typical California prescriber of this medication (48). Medicare paid an average of $2.94 per fill, versus $26.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 98.3 30-Day Fills standardized to 30-day supplies 2,242 Days of Medication total across all patients in 2023 | |||
| Abiraterone Acetate | 96 | $5,294.32 | ▲ More than typical |
About Abiraterone Acetate: This medication is used to treat prostate cancer. Show more ▾ Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children. An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER. In 2023, this provider wrote 96 Medicare prescriptions for Abiraterone Acetate, about 2 times the volume of the typical California prescriber of this medication (48). Medicare paid an average of $5,294.32 per fill, versus $1,946.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96 30-Day Fills standardized to 30-day supplies 2,880 Days of Medication total across all patients in 2023 | |||
| EliquisApixaban | 90 | $934.35 | ▲ More than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 90 Medicare prescriptions for Eliquis, about 1.3 times the volume of the typical California prescriber of this medication (68). Medicare paid an average of $934.35 per fill, versus $848.49 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 150 30-Day Fills standardized to 30-day supplies 4,477 Days of Medication total across all patients in 2023 | |||
| Ondansetron HclOndansetron Hcl/Pf | 89 | $1.58▼ below CA avg | ▲ More than typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 89 Medicare prescriptions for Ondansetron Hcl, about 3 times the volume of the typical California prescriber of this medication (30). Medicare paid an average of $1.58 per fill, versus $8.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 91.1 30-Day Fills standardized to 30-day supplies 2,039 Days of Medication total across all patients in 2023 | |||
| FamotidineFamotidine/Pf | 66 | $1.50▼ below CA avg | ▲ More than typical |
About Famotidine: Famotidine is used to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed. Show more ▾ This medication is also used to treat certain stomach and throat (esophagus) problems (such as erosive esophagitis, gastroesophageal reflux disease-GERD, Zollinger-Ellison syndrome). It works by decreasing the amount of acid your stomach makes. It relieves symptoms such as cough that doesn't go away, stomach pain, heartburn, and difficulty swallowing. Famotidine belongs to a class of drugs known as H2 blockers. This medication is also available without a prescription. It is used to prevent and treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). If you are taking this medication for self-treatment, it is important to read the manufacturer's package instructions carefully so you know when to consult your doctor or pharmacist. A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion. In 2023, this provider wrote 66 Medicare prescriptions for Famotidine, about 1.3 times the volume of the typical California prescriber of this medication (51). Medicare paid an average of $1.50 per fill, versus $6.17 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 67.9 30-Day Fills standardized to 30-day supplies 1,569 Days of Medication total across all patients in 2023 | |||
| Diphenhydramine Hcl | 63 | $3.31▼ below CA avg | ▲ More than typical |
About Diphenhydramine Hcl: Diphenhydramine injection is an antihistamine used to treat life-threatening allergic reactions (anaphylaxis) along with epinephrine and other treatments. Show more ▾ It is also used to relieve symptoms of household allergies, hay fever and the common cold when medication cannot be given by mouth. Common allergy symptoms relieved by antihistamines include rash, itching, watery eyes, itchy eyes/nose/throat, cough, runny nose and sneezing. It is also used to treat nausea, vomiting and dizziness caused by motion sickness when medication cannot be given by mouth. Diphenhydramine works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Its drying effects on such symptoms as watery eyes and runny nose are caused by blocking another natural substance made by your body (acetylcholine). Diphenhydramine should not be used in newborns or premature infants because of an increased risk of side effects. It should not be used for common cold symptoms in children less than 6 years of age due to the risk of serious side effects, such as slow/shallow breathing. Cough-and-cold products have not been shown to be safe or effective in children younger than 6. In 2023, this provider wrote 63 Medicare prescriptions for Diphenhydramine Hcl, about 2 times the volume of the typical California prescriber of this medication (31). Medicare paid an average of $3.31 per fill, versus $29.48 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 63.2 30-Day Fills standardized to 30-day supplies 1,444 Days of Medication total across all patients in 2023 | |||
| Ondansetron OdtOndansetron | 48 | $14.49▼ below CA avg | ▲ More than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2023, this provider wrote 48 Medicare prescriptions for Ondansetron Odt, about 2.2 times the volume of the typical California prescriber of this medication (22). Medicare paid an average of $14.49 per fill, versus $21.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 48 30-Day Fills standardized to 30-day supplies 560 Days of Medication total across all patients in 2023 | |||
| Oxaliplatin | 42 | $105.01▼ below CA avg | ▲ More than typical |
About Oxaliplatin: This medication is used to treat advanced cancer of the colon and rectum. Show more ▾ Oxaliplatin is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth. An organoplatinum complex in which the platinum atom is complexed with 1,2-diaminocyclohexane, and with an oxalate ligand which is displaced to yield active oxaliplatin derivatives. These derivatives form inter- and intra-strand DNA crosslinks that inhibit DNA replication and transcription. Oxaliplatin is an antineoplastic agent that is often administered with FLUOROURACIL and FOLINIC ACID in the treatment of metastatic COLORECTAL NEOPLASMS. In 2023, this provider wrote 42 Medicare prescriptions for Oxaliplatin, about 1.5 times the volume of the typical California prescriber of this medication (28). Medicare paid an average of $105.01 per fill, versus $295.51 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 42 30-Day Fills standardized to 30-day supplies 903 Days of Medication total across all patients in 2023 | |||
| Dexamethasone | 32 | $21.72 | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2023, this provider wrote 32 Medicare prescriptions for Dexamethasone, about the same volume as the typical California prescriber of this medication (32). Medicare paid an average of $21.72 per fill, versus $19.76 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.5 30-Day Fills standardized to 30-day supplies 842 Days of Medication total across all patients in 2023 | |||
| Hydroxyurea | 30 | $39.89▼ below CA avg | ≈ Typical |
About Hydroxyurea: This medication is used by people with sickle cell anemia to reduce the number of painful crises caused by the disease and to reduce the need for blood transfusions. Show more ▾ Some brands are also used to treat certain types of cancer (such as chronic myelogenous leukemia, squamous cell carcinomas). An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. In 2023, this provider wrote 30 Medicare prescriptions for Hydroxyurea, about the same volume as the typical California prescriber of this medication (33). Medicare paid an average of $39.89 per fill, versus $42.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 70.5 30-Day Fills standardized to 30-day supplies 2,116 Days of Medication total across all patients in 2023 | |||
| Letrozole | 28 | $46.89 | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2023, this provider wrote 28 Medicare prescriptions for Letrozole, about half the volume of the typical California prescriber of this medication (48). Medicare paid an average of $46.89 per fill, versus $32.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69.2 30-Day Fills standardized to 30-day supplies 2,077 Days of Medication total across all patients in 2023 | |||
| Lupron DepotLeuprolide Acetate | 26 | $5,732.45 | ≈ Typical |
About Lupron Depot: Leuprolide is used to treat advanced prostate cancer. Show more ▾ It is not a cure. Most types of prostate cancer need the hormone testosterone to grow and spread. Leuprolide works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells and helps relieve symptoms such as painful/difficult urination. Talk to your doctor about the risks and benefits of treatment. A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. In 2023, this provider wrote 26 Medicare prescriptions for Lupron Depot, about 84% of the volume of the typical California prescriber of this medication (31). Medicare paid an average of $5,732.45 per fill, versus $4,304.66 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 78 30-Day Fills standardized to 30-day supplies 2,340 Days of Medication total across all patients in 2023 | |||
| Carboplatin | 24 | $56.47 | ≈ Typical |
About Carboplatin: Carboplatin is used to treat various types of cancer. Show more ▾ It is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth. An organoplatinum compound that possesses antineoplastic activity. In 2023, this provider wrote 24 Medicare prescriptions for Carboplatin, about 86% of the volume of the typical California prescriber of this medication (28). Medicare paid an average of $56.47 per fill, versus $56.15 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24.2 30-Day Fills standardized to 30-day supplies 562 Days of Medication total across all patients in 2023 | |||
| ZarxioFilgrastim-Sndz | 24 | $1,071.73▼ below CA avg | ≈ Typical |
About Zarxio: Filgrastim is a man-made version of a certain natural substance made by your body. Show more ▾ It is used to help your body make more white blood cells. White blood cells are important to help you fight off infections. Filgrastim is given to people whose ability to make white blood cells is reduced (for instance, due to chemotherapy, chronic neutropenia, or exposure to large amounts of radiation). It is also used in certain treatment procedures (such as bone marrow/stem cell transplant). This monograph is about the following filgrastim products: filgrastim, tbo-filgrastim, filgrastim-sndz, filgrastim-aafi, and filgrastim-ayow. A recombinant granulocyte colony-stimulating factor (G-CSF) that is used in the treatment and prevention of NEUTROPENIA, preparation and collection of blood progenitor cells, and for use in PERIPHERAL BLOOD STEM CELL TRANSPLANTATION. In 2023, this provider wrote 24 Medicare prescriptions for Zarxio, about the same volume as the typical California prescriber of this medication (23). Medicare paid an average of $1,071.73 per fill, versus $1,510.99 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 24 30-Day Fills standardized to 30-day supplies 470 Days of Medication total across all patients in 2023 | |||
| MvasiBevacizumab-Awwb | 23 | $6,427.00▼ below CA avg | ▼ Less than typical |
About Mvasi: This medication is a man-made antibody (IgG1) used to treat various types of cancer. Show more ▾ This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, bevacizumab-bvzr, and bevacizumab-maly. An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS. In 2023, this provider wrote 23 Medicare prescriptions for Mvasi, about half the volume of the typical California prescriber of this medication (47). Medicare paid an average of $6,427.00 per fill, versus $6,594.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 23 30-Day Fills standardized to 30-day supplies 483 Days of Medication total across all patients in 2023 | |||
| TecentriqAtezolizumab | 22 | $10,161.35▼ below CA avg | ≈ Typical |
About Tecentriq: This medication is used to treat various cancers (such as liver/lung/skin cancer, alveolar soft part sarcoma - ASPS). Show more ▾ It works by helping your immune system fight the cancer. Atezolizumab belongs to a class of drugs known as monoclonal antibodies. In 2023, this provider wrote 22 Medicare prescriptions for Tecentriq, about the same volume as the typical California prescriber of this medication (21). Medicare paid an average of $10,161.35 per fill, versus $10,654.57 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 22 30-Day Fills standardized to 30-day supplies 462 Days of Medication total across all patients in 2023 | |||
| Cyclophosphamide | 21 | $626.54▼ below CA avg | ≈ Typical |
About Cyclophosphamide: Cyclophosphamide is used to treat various types of cancer. Show more ▾ It is a chemotherapy drug that works by slowing or stopping cell growth. Cyclophosphamide also works by decreasing your immune system's response to various diseases. It is used to treat a certain type of kidney disease in children after other treatments have not worked. Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. In 2023, this provider wrote 21 Medicare prescriptions for Cyclophosphamide, about 1.2 times the volume of the typical California prescriber of this medication (17). Medicare paid an average of $626.54 per fill, versus $686.90 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 21 30-Day Fills standardized to 30-day supplies 441 Days of Medication total across all patients in 2023 | |||
| Paclitaxel | 20 | $108.01▼ below CA avg | ≈ Typical |
About Paclitaxel: Paclitaxel is used to treat various types of cancer. Show more ▾ It is a cancer chemotherapy drug that works by slowing or stopping cancer cell growth. A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death. In 2023, this provider wrote 20 Medicare prescriptions for Paclitaxel, about the same volume as the typical California prescriber of this medication (21). Medicare paid an average of $108.01 per fill, versus $141.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 20.2 30-Day Fills standardized to 30-day supplies 471 Days of Medication total across all patients in 2023 | |||
| KeytrudaPembrolizumab | 20 | $11,410.21▼ below CA avg | ▼ Less than typical |
About Keytruda: Pembrolizumab is used to treat cancer. Show more ▾ It works by changing the action of your own immune system, directing it to attack cancer cells. Pembrolizumab belongs to a class of drugs known as monoclonal antibodies. In 2023, this provider wrote 20 Medicare prescriptions for Keytruda, about 74% of the volume of the typical California prescriber of this medication (27). Medicare paid an average of $11,410.21 per fill, versus $11,737.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 20 30-Day Fills standardized to 30-day supplies 429 Days of Medication total across all patients in 2023 | |||
| Zoledronic Acid | 19 | $170.26 | ▲ More than typical |
About Zoledronic Acid: This medication is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer. Show more ▾ Zoledronic acid is also used with cancer chemotherapy to treat bone problems that may occur with multiple myeloma and other types of cancer (such as breast, lung) that have spread to the bones. Zoledronic acid belongs to a class of drugs known as bisphosphonates. It lowers high blood calcium levels by reducing the amount of calcium released from your bones into your blood. It also works by slowing the breakdown of your bones by cancer to prevent bone fractures. An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS. In 2023, this provider wrote 19 Medicare prescriptions for Zoledronic Acid, about 1.5 times the volume of the typical California prescriber of this medication (13). Medicare paid an average of $170.26 per fill, versus $168.07 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 594 Days of Medication total across all patients in 2023 | |||
| Doxorubicin Hcl | 19 | $37.44▼ below CA avg | ≈ Typical |
About Doxorubicin Hcl: Doxorubicin is an anthracycline type of chemotherapy that is used to treat several different types of cancer. Show more ▾ Doxorubicin works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 19 Medicare prescriptions for Doxorubicin Hcl, about the same volume as the typical California prescriber of this medication (17). Medicare paid an average of $37.44 per fill, versus $57.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 19 30-Day Fills standardized to 30-day supplies 399 Days of Medication total across all patients in 2023 | |||
| Imatinib Mesylate | 18 | $8,582.52 | ≈ Typical |
About Imatinib Mesylate: This medication is used to treat certain types of cancer (such as acute lymphoblastic leukemia, chronic myeloid leukemia, gastrointestinal stromal tumors, and myelodysplastic/myeloproliferative diseases). Show more ▾ It works by slowing or stopping the growth of cancer cells. Imatinib may also be used to treat certain immune system disorders (such as aggressive systemic mastocytosis, hypereosinophilic syndrome). A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors. In 2023, this provider wrote 18 Medicare prescriptions for Imatinib Mesylate, about 82% of the volume of the typical California prescriber of this medication (22). Medicare paid an average of $8,582.52 per fill, versus $1,586.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 18 30-Day Fills standardized to 30-day supplies 540 Days of Medication total across all patients in 2023 | |||
| Gemcitabine Hcl | 15 | $183.83▼ below CA avg | ▼ Less than typical |
About Gemcitabine Hcl: Gemcitabine is used to treat certain types of cancer (including biliary tract, breast, lung, ovarian, pancreatic). Show more ▾ It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 15 Medicare prescriptions for Gemcitabine Hcl, about half the volume of the typical California prescriber of this medication (28). Medicare paid an average of $183.83 per fill, versus $257.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 15 30-Day Fills standardized to 30-day supplies 322 Days of Medication total across all patients in 2023 | |||
| RuxienceRituximab-Pvvr | 15 | $5,694.13▼ below CA avg | ≈ Typical |
About Ruxience: Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). Show more ▾ It works by slowing or stopping the growth of cancer cells. Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions. This monograph is about the following rituximab products: rituximab, rituximab-abbs, rituximab-arrx, and rituximab-pvvr. In 2023, this provider wrote 15 Medicare prescriptions for Ruxience, about the same volume as the typical California prescriber of this medication (14). Medicare paid an average of $5,694.13 per fill, versus $6,564.49 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 16.7 30-Day Fills standardized to 30-day supplies 406 Days of Medication total across all patients in 2023 | |||
| ZirabevBevacizumab-Bvzr | 14 | $5,183.84▼ below CA avg | ▼ Less than typical |
About Zirabev: This medication is a man-made antibody (IgG1) used to treat various types of cancer. Show more ▾ This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, bevacizumab-bvzr, and bevacizumab-maly. In 2023, this provider wrote 14 Medicare prescriptions for Zirabev, about 67% of the volume of the typical California prescriber of this medication (21). Medicare paid an average of $5,183.84 per fill, versus $5,737.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 14 30-Day Fills standardized to 30-day supplies 294 Days of Medication total across all patients in 2023 | |||
| Magnesium Sulfate | 13 | $3.03▼ below CA avg | ▼ Less than typical |
About Magnesium Sulfate: A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. In 2023, this provider wrote 13 Medicare prescriptions for Magnesium Sulfate, about 62% of the volume of the typical California prescriber of this medication (21). Medicare paid an average of $3.03 per fill, versus $31.78 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13.4 30-Day Fills standardized to 30-day supplies 294 Days of Medication total across all patients in 2023 | |||
| Palonosetron Hcl | 13 | $43.11▼ below CA avg | ▼ Less than typical |
About Palonosetron Hcl: This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Show more ▾ It is also used to prevent nausea and vomiting after surgery. Palonosetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. In 2023, this provider wrote 13 Medicare prescriptions for Palonosetron Hcl, about 17% of the volume of the typical California prescriber of this medication (78). Medicare paid an average of $43.11 per fill, versus $106.99 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13.2 30-Day Fills standardized to 30-day supplies 287 Days of Medication total across all patients in 2023 | |||
| Tamoxifen Citrate | 13 | $60.61 | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2023, this provider wrote 13 Medicare prescriptions for Tamoxifen Citrate, about a third of the volume of the typical California prescriber of this medication (34). Medicare paid an average of $60.61 per fill, versus $36.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35.2 30-Day Fills standardized to 30-day supplies 1,057 Days of Medication total across all patients in 2023 | |||
| Cisplatin | 13 | $51.36▼ below CA avg | ▼ Less than typical |
About Cisplatin: Cisplatin is used to treat various types of cancer. Show more ▾ It is a chemotherapy drug that contains platinum. It is used to slow or stop cancer cell growth. An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. In 2023, this provider wrote 13 Medicare prescriptions for Cisplatin, about 65% of the volume of the typical California prescriber of this medication (20). Medicare paid an average of $51.36 per fill, versus $61.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13.4 30-Day Fills standardized to 30-day supplies 294 Days of Medication total across all patients in 2023 | |||
| Bortezomib | 13 | $622.52▼ below CA avg | ≈ Typical |
About Bortezomib: This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). Show more ▾ It works by slowing or stopping the growth of cancer cells. A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA. In 2023, this provider wrote 13 Medicare prescriptions for Bortezomib, about 81% of the volume of the typical California prescriber of this medication (16). Medicare paid an average of $622.52 per fill, versus $2,558.52 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13 30-Day Fills standardized to 30-day supplies 280 Days of Medication total across all patients in 2023 | |||
| Lenalidomide | 13 | $9,765.45▼ below CA avg | ▼ Less than typical |
About Lenalidomide: Lenalidomide is used to treat various types of cancers. Show more ▾ It works by slowing or stopping the growth of cancer cells. It is also used to treat anemia in patients with certain blood/bone marrow disorders (myelodysplastic syndromes-MDS). Lenalidomide may lessen the need for blood transfusions. Lenalidomide is not recommended for the treatment of a certain type of cancer (chronic lymphocytic leukemia) because of the increased risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the risks of using this medication. A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. In 2023, this provider wrote 13 Medicare prescriptions for Lenalidomide, about half the volume of the typical California prescriber of this medication (26). Medicare paid an average of $9,765.45 per fill, versus $12,446.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 13 30-Day Fills standardized to 30-day supplies 273 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 12 | $7.65▼ below CA avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 12 Medicare prescriptions for Alendronate Sodium, about a quarter of the volume of the typical California prescriber of this medication (58). Medicare paid an average of $7.65 per fill, versus $12.46 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 31.8 30-Day Fills standardized to 30-day supplies 952 Days of Medication total across all patients in 2023 | |||
| Fosaprepitant Dimeglumine | 12 | $68.94▼ below CA avg | ▼ Less than typical |
About Fosaprepitant Dimeglumine: Fosaprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Show more ▾ Fosaprepitant works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting. This medication will not treat nausea or vomiting that has already started. Ask your doctor what you should do if you already have nausea or vomiting. In 2023, this provider wrote 12 Medicare prescriptions for Fosaprepitant Dimeglumine, about half the volume of the typical California prescriber of this medication (26). Medicare paid an average of $68.94 per fill, versus $224.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12 30-Day Fills standardized to 30-day supplies 252 Days of Medication total across all patients in 2023 | |||
| Vincristine Sulfate | 11 | $9.91 | ≈ Typical |
About Vincristine Sulfate: Vincristine is used to treat various types of cancer. Show more ▾ It is a cancer chemotherapy drug that is usually used with other chemotherapy drugs to slow or stop cancer cell growth. An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) In 2023, this provider wrote 11 Medicare prescriptions for Vincristine Sulfate, about 85% of the volume of the typical California prescriber of this medication (13). Medicare paid an average of $9.91 per fill, versus $9.51 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 231 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for EDDIE THARA D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Downey, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
